These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


465 related items for PubMed ID: 8154043

  • 1. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW.
    Transplantation; 1994 Mar 27; 57(6):933-41. PubMed ID: 8154043
    [Abstract] [Full Text] [Related]

  • 2. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B, Wieder KJ, Hancock WW, Zheng XX, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1996 Jan 01; 156(1):395-404. PubMed ID: 8598490
    [Abstract] [Full Text] [Related]

  • 3. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 4. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ, Hancock WW, Schmidbauer G, Corpier CL, Wieder I, Kobzik L, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1993 Jul 15; 151(2):1158-66. PubMed ID: 8335897
    [Abstract] [Full Text] [Related]

  • 5. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB.
    Transplantation; 1993 May 15; 55(5):1112-8. PubMed ID: 8497891
    [Abstract] [Full Text] [Related]

  • 6. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW, DiStefano R, Braun P, Schweizer RT, Tilney NL, Kupiec-Weglinski JW.
    Transplantation; 1990 Feb 15; 49(2):416-21. PubMed ID: 2106180
    [Abstract] [Full Text] [Related]

  • 8. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G, Hancock WW, Wasowska B, Binder J, Padberg W, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 15; 27(1):427-9. PubMed ID: 7879048
    [No Abstract] [Full Text] [Related]

  • 9. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
    Binder J, Graser E, Hancock WW, Wasowska B, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1995 Dec 27; 60(12):1516-24. PubMed ID: 8545884
    [Abstract] [Full Text] [Related]

  • 10. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
    Heidecke CD, Zantl N, Maier S, Sewczik T, Westerholt S, Jakobs F, Westerholt A, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1998 Nov 27; 66(10):1354-61. PubMed ID: 9846522
    [Abstract] [Full Text] [Related]

  • 11. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
    Kupiec-Weglinski JW, Sablinski T, Hancock WW, Di Stefano R, Mariani G, Mix CT, Tilney NL.
    Transplantation; 1991 Feb 27; 51(2):300-5. PubMed ID: 1825240
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN, Maguire JA, Hancock WW.
    Transplantation; 1993 Dec 27; 56(6):1309-14. PubMed ID: 8278994
    [Abstract] [Full Text] [Related]

  • 13. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW, Sayegh MH, Sablinski T, Kut JP, Kupiec-Weglinski JW, Milford EL.
    Transplantation; 1992 Jun 27; 53(6):1276-80. PubMed ID: 1604485
    [Abstract] [Full Text] [Related]

  • 14. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
    Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1995 Feb 27; 59(4):590-7. PubMed ID: 7878763
    [Abstract] [Full Text] [Related]

  • 15. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH, Schaub M, Magee CC, Kupiec-Weglinski JW, Sayegh MH.
    J Heart Lung Transplant; 2000 Jun 27; 19(6):566-75. PubMed ID: 10867337
    [Abstract] [Full Text] [Related]

  • 16. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
    Candinas D, Belliveau S, Koyamada N, Miyatake T, Hechenleitner P, Mark W, Bach FH, Hancock WW.
    Transplantation; 1996 Dec 27; 62(12):1920-7. PubMed ID: 8990388
    [Abstract] [Full Text] [Related]

  • 17. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 27; 27(1):423-6. PubMed ID: 7879047
    [No Abstract] [Full Text] [Related]

  • 18. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1994 Jul 15; 58(1):80-6. PubMed ID: 8036712
    [Abstract] [Full Text] [Related]

  • 19. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A.
    Ann Transplant; 1998 Jul 15; 3(1):28-33. PubMed ID: 9869895
    [Abstract] [Full Text] [Related]

  • 20. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.